Top Stories Telix Pharmaceuticals Achieves Revenue Milestone with Strong Q4 Growth Telix Pharmaceuticals Ltd (ASX: TLX) reported a significant milestone, achieving its full year revenue guidance with a total of US$804 million, aligning with its... Editorial20 January, 2026